Aquinox Pharmaceuticals set to acquire University of Wash. spinout Neoleukin Therapeutics

This post was originally published on this site
Neoleukin Therapeutics launched in January with the goal of commercializing a cancer-fighting protein that was designed from scratch at the University of Washington. (Neoleukin Photo)

Vancouver, B.C.-based Aquinox Pharmaceuticals is set to buy Neoleukin Therapeutics, a Seattle startup that launched out of the University of Washington just eight

contactedorg

Check out http://contacted.org